Want to see VMD full AI Analyst Report?
VMD Stock Chart & Stats
$6.88
$0.08(0.94%)
At close: 4:00 PM EST
$6.88
$0.08(0.94%)
Day’s Range― - ―
52-Week Range$5.93 - $12.61
Previous CloseN/A
Volume27.16K
Average Volume (3M)322.00K
Market Cap
$465.79M
Enterprise Value$286.90
Total Cash (Recent Filing)$9.76M
Total Debt (Recent Filing)$12.44M
Price to Earnings (P/E)30.9
Beta0.62
Next Earnings
Aug 12, 2026EPS Estimate
0.12Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.39
Shares Outstanding38,336,803
10 Day Avg. Volume318,195
30 Day Avg. Volume322,001
Financial Highlights & Ratios
PEG Ratio0.63
Price to Book (P/B)2.04
Price to Sales (P/S)1.07
P/FCF Ratio24.22
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.46
Revenue Forecast (FY)$317.30M
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet, Low LeverageVery low TTM debt-to-equity (~0.09) and an improving equity base provide durable financial flexibility. This conservative capital structure supports continued tuck-in M&A, buybacks, or working-capital swings, and reduces refinancing risk versus peers during reimbursement or demand cycles.
Diversifying Revenue Mix And Strong Sleep/maternal GrowthRapid PAP resupply growth, accretive maternal-health integration and 2x equipment/supply sales materially reduce reliance on ventilator rentals. A broader, recurring revenue base and cross-selling into maternal and sleep segments improves resilience and capital efficiency over the medium term.
High Margins With Improving Cash GenerationConsistently strong gross and EBITDA margins indicate durable unit economics in home respiratory care. The recent surge in TTM free cash flow reflects improving working-capital and capex discipline, supporting reinvestment and shareholder returns while retaining margin resilience.
Bears Say
NCD-driven Ventilator Census PressurePolicy changes under the NCD increase compliance evaluations and episodic loss of ventilator access, driving higher patient turnover and censor volatility. That structural reimbursement/coverage pressure can depress recurring rental revenue and utilization for multiple quarters and raises administrative burden.
Volatile Free Cash Flow ConversionWide swings in free cash flow driven by working-capital and timing effects reduce predictability of internally funded growth or buybacks. Even after a TTM rebound, FCF remains materially below net income (~45% of net income), implying ongoing reinvestment needs and less consistent cash conversion.
Expanded LTIP Increases Potential DilutionThe approved expansion of the long-term incentive pool materially raises the ceiling for equity-based awards. While it helps attract and retain talent, progressive issuance could dilute existing shareholders and pressure EPS over the medium term if grants are sizable and sustained.
Viemed Healthcare News
VMD FAQ
What was Viemed Healthcare US’s price range in the past 12 months?
Viemed Healthcare US lowest stock price was $5.93 and its highest was $12.61 in the past 12 months.
What is Viemed Healthcare US’s market cap?
Viemed Healthcare US’s market cap is $465.79M.
When is Viemed Healthcare US’s upcoming earnings report date?
Viemed Healthcare US’s upcoming earnings report date is Aug 12, 2026 which is in 22 days.
How were Viemed Healthcare US’s earnings last quarter?
Viemed Healthcare US released its earnings results on May 05, 2026. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by -$0.03.
Is Viemed Healthcare US overvalued?
According to Wall Street analysts Viemed Healthcare US’s price is currently Overvalued.
Does Viemed Healthcare US pay dividends?
Viemed Healthcare US does not currently pay dividends.
What is Viemed Healthcare US’s EPS estimate?
Viemed Healthcare US’s EPS estimate is 0.12.
How many shares outstanding does Viemed Healthcare US have?
Viemed Healthcare US has 38,336,803 shares outstanding.
What happened to Viemed Healthcare US’s price movement after its last earnings report?
Viemed Healthcare US reported an EPS of $0.06 in its last earnings report, missing expectations of $0.09. Following the earnings report the stock price went down -12.216%.
Which hedge fund is a major shareholder of Viemed Healthcare US?
Currently, no hedge funds are holding shares in VMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Viemed Healthcare Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
VMD Sentiment 70%
Sector Average 66%
Sector Average 66%
Hedge Fund Trend
Increased
By 7.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $347.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.5%
Last 30 Days ▲ 5.6%
Last 30 Days ▲ 5.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
84.43%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
10.83%
Trailing 12-Months
Company Description
Viemed Healthcare US
Viemed Healthcare, Inc., through its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The company provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. It also sells and rents HME devices, such as non-invasive and invasive ventilators, positive airway pressure (PAP) machines, durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment. In addition, the company provides neuromuscular care and oxygen therapy services; and sleep apnea management which provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, it offers in-home sleep apnea testing services; and breast pumps and related lactation equipment and supplies, including fulfillment and support services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
Technical Analysis
Ownership Overview
13.67% Insiders
13.07% Mutual Funds
0.46% Other Institutional Investors
64.15% Public Companies and
Individual Investors